30M Genomics: Financial Breakdown
Decoding financial health metrics of 30M Genomics
Total Revenue₹15.2 Lakh-15%Prev. FY
Total Expenses₹37.2 Lakh-9%Prev. FY
Profit After Tax₹-22.2 Lakh-3%Prev. FY
Total Assets₹76.1 Lakh57%Prev. FY
Net Profit Margin-146.8%-20%Prev. FY
Note: Above mentioned stats are for FY24-25
FAQs on Financials of 30M Genomics
No. In FY25, 30M Genomics reported a net loss of ₹22.2 Lakh, so it was not profitable.
30M Genomics's revenue declined 14.3% year-on-year, from ₹17.7 Lakh in FY24 to ₹15.2 Lakh in FY25.
In FY25, 30M Genomics posted revenue of ₹15.2 Lakh (down 14.3% YoY) and a net loss of ₹22.2 Lakh. Explore the full financials of 30M Genomics here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links